MDGL | Madrigal Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	N/A - N/A
52 Week Range	N/A - N/A
Beta	-0.09
Implied Volatility	61.15%
IV Rank	29.28%
Day's Volume	N/A
Average Volume	N/A
Shares Outstanding	N/A
Market Cap	N/A
Sector	Healthcare
Industry	Biotechnology
IPO Date	2007-02-06

Valuation
Profitability
Growth
Health
P/E Ratio	N/A
Forward P/E Ratio	N/A
EPS	N/A
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	376
Country	USA
Website	MDGL

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.

MDGL's peers: ABCL, ACAD, ADMA, AGEN, AKRO, ALNY, ALT, APLS, ARCT, ASND, ATNM, AUPH, AVXL, AXSM, BBIO, BCRX, BLUE, BNTX, BPMC, BTAI, CABA, CPRX, ETNB, EXEL, GALT, GERN, IBRX, IMVT, IONS, IOVA, KOD, LEGN, ICPT, TGTX, TERN, HEPA, VKTX, SRPT, PTCT, DAWN, XFOR, INZY, ABOS, MREO, PLRX, ACLX, STOK, KRYS, NVO, PBYI, PRTA, RCUS, REGN, RPRX, SAGE, SAVA, VIR, VRNA, VRTX, ZLAB

*Chart delayed

Analyzing fundamentals for MDGL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see MDGL Fundamentals page.

Watching at MDGL technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on MDGL Technicals page.